Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,424,828
-$94,663 QoQ
Shares Held
27,181
-1.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#304
of 1,032 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AUXIER ASSET MANAGEMENT LLC holds $26,865,861 across 7 Drug Manufacturers - General names. GSK ranks #4 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
69,837 | $17,736,502 | |
| 2 | AMGN |
Amgen Inc
|
8,785 | $3,181,224 | |
| 3 | PFE |
Pfizer Inc
|
60,974 | $1,468,253 | |
| 4 | GSK |
GSK plc
This page
|
27,181 | $1,424,828 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
21,671 | $1,248,683 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
8,611 | $1,087,913 | |
| 7 | LLY |
ELI LILLY & Co
|
599 | $718,458 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,424,828 | 27,181 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,519,491 | 27,532 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,350,169 | 27,532 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,217,586 | 28,211 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $1,096,012 | 28,542 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,117,532 | 28,847 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $993,022 | 29,362 | Shares | Sole | 2025-02-19 | |
| 2024-09-30 | $1,275,128 | 31,192 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,214,752 | 31,552 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,359,493 | 31,712 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,244,919 | 33,592 | Shares | Sole | 2024-02-22 | |
| 2023-09-30 | $1,279,480 | 35,296 | Shares | Sole | 2023-11-21 | |
| 2023-06-30 | $1,264,364 | 35,476 | Shares | Sole | 2023-08-17 | |
| 2023-03-31 | $1,237,152 | 34,771 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,233,519 | 35,103 | Shares | Sole | 2023-02-17 | |
| 2022-09-30 | $1,043,617 | 35,461 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $1,960,561 | 45,921 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,962,767 | 45,941 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $2,240,563 | 51,801 | Shares | Sole | 2022-03-01 | |
| 2021-09-30 | $1,946,372 | 51,936 | Shares | Sole | 2021-11-18 | |
| 2021-06-30 | $2,044,006 | 52,336 | Shares | Sole | 2021-08-18 | |
| 2021-03-31 | $1,904,468 | 54,406 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,025,058 | 56,106 | Shares | Sole | 2021-03-05 | |
| 2020-09-30 | $2,076,451 | 56,246 | Shares | Sole | 2021-03-05 | |
| 2020-06-30 | $2,262,226 | 56,546 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $2,094,144 | 56,351 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||